Back
Kymera Therapeutics Stock Predictions
![](/images/offers/ims/large/offer11.jpg)
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54
KYMR
Kymera Therapeutics
Last Price:
44.79
Seasonality Move:
25.63%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer9.jpg)
BRICS Plans to End US Dollar Dominance
Learn MoreKymera Therapeutics Stock Forecast
- Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 52% based on the past 4 years of stock performance.
- Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Kymera Therapeutics Stock Undervalued?
The current Kymera Therapeutics [KYMR] share price is $44.77. The Score for KYMR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal. - KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Kymera Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 52% based on the past 4 years of stock performance.
Kymera Therapeutics Stock Rating
Buy
54
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics overpriced?
- Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Kymera Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kymeratx.com
52-Week Data
52-Week High:
50.19
52-Week Low:
9.60
Prediction Charts
Market Cap:
2.76B
Price in USD:
44.77
Volume:
275.65K
Beta:
2.20
Technical Analysis
SMA50:
43.27
SMA100:
38.69
SMA200:
35.70
52-Wk Change:
134.64%
Stock Predictions
-
Is Kymera Therapeutics stock public?
Yes, Kymera Therapeutics is a publicly traded company. -
What is the Kymera Therapeutics stock quote today?
The Kymera Therapeutics stock price is 44.77 USD today. -
How to buy Kymera Therapeutics stock online?
You can buy Kymera Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-22 | 48.60 | 45.85 | 48.60 | 45.02 |
Aug-23 | 46.49 | 47.78 | 47.87 | 45.81 |
Aug-26 | 49.58 | 49.75 | 50.19 | 48.14 |
Aug-27 | 49.06 | 48.94 | 49.43 | 48.20 |
Aug-28 | 48.86 | 48.52 | 49.96 | 47.88 |
Aug-29 | 48.76 | 48.25 | 49.89 | 48.10 |
Aug-30 | 48.50 | 48.36 | 49.22 | 47.41 |
Sep-3 | 47.70 | 46.27 | 48.84 | 46.26 |
Sep-4 | 45.92 | 46.17 | 47.10 | 45.39 |
Sep-5 | 46.29 | 46.60 | 46.69 | 45.34 |
Sep-6 | 47.04 | 45.40 | 48.53 | 43.90 |
Sep-9 | 46.06 | 46.19 | 47.02 | 45.66 |
Sep-10 | 46.56 | 46.88 | 46.93 | 44.95 |
Sep-11 | 46.49 | 44.77 | 46.90 | 44.65 |
Kymera Therapeutics Earnings
Kymera Therapeutics Earnings Report: Per Share Kymera Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Kymera Therapeutics Forecast Revenue Growth
Kymera Therapeutics Stock Analysis: Historical quarterly revenues per share for Kymera Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.51 per share.
* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.